# Erythema Nodosum

Erythema nodosum requires confirmation of a septal panniculitis pattern and a targeted search for infection, sarcoidosis, inflammatory bowel disease, medication exposure, pregnancy, and systemic inflammatory disease. Management prioritizes identifying the trigger while treating pain and monitoring for atypical or persistent disease.

**Clinical question:** How should physicians confirm erythema nodosum, identify its cause, and select targeted management?

Updated: 2026-09-15T23:20:25.586538+00:00

## What matters in practice
- Treat erythema nodosum as a reaction pattern rather than a final diagnosis; recent streptococcal illness, tuberculosis, deep fungal infection, sarcoidosis, inflammatory bowel disease, pregnancy, and medications are key etiologic branches. [18][20]
- Obtain a careful exposure and systems history, examine for extracutaneous disease, and include chest imaging in the etiologic evaluation because it may reveal tuberculosis, sarcoidosis, or deep fungal infection. [19]
- Use deep incisional or excisional biopsy when lesions are atypical, ulcerated, persistent, unilateral, or when an alternative panniculitis or vasculitis would change management; classic erythema nodosum is a panniculitis centered in subcutaneous fat. [3][11][12]
- In patients with known inflammatory bowel disease, erythema nodosum often tracks intestinal disease activity; assess objective inflammatory activity and optimize bowel disease management rather than treating the skin finding in isolation. [5][8][17]

## Confirm the clinical pattern and identify presentations that need biopsy

Classify the eruption before assigning an etiologic workup.

The usual erythema nodosum phenotype is acute tender erythematous-to-violaceous subcutaneous nodules, predominantly on the pretibial legs. Fever, arthralgia, and ankle-predominant joint symptoms can accompany the eruption and do not independently establish a specific cause. [1][18][20]

Do not assume that every painful leg nodule is erythema nodosum. Ulceration, drainage, marked asymmetry, fixed plaque-like lesions, neuropathy, widespread papules or pustules, or a prolonged relapsing course should prompt reassessment for other inflammatory, infectious, malignant, or leprosy-associated nodular disorders. Erythema nodosum leprosum, for example, may occur with nodules plus ulcers, sensory loss, systemic inflammation, cytopenias, or hepatosplenomegaly. [16][19]

Perform a biopsy when morphology is atypical or the diagnosis will alter treatment. Sample sufficient subcutaneous tissue, because erythema nodosum is a panniculitis involving subcutaneous adipose tissue; a superficial specimen can miss the diagnostic compartment. [3][11][12]
- Document onset, distribution, lesion evolution, ulceration, fever, arthralgia, respiratory symptoms, pharyngitis, diarrhea, abdominal pain, oral or genital aphthae, ocular symptoms, pregnancy, and new medications. These features direct the etiologic branch. [4][18][20]
- Escalate the examination beyond the legs when systemic clues are present: inspect for acneiform or papulopustular lesions, oral/genital ulceration, eye inflammation, lymphadenopathy, hepatosplenomegaly, and sensory changes. [4][16]

*Clinical findings that should redirect the initial erythema nodosum assessment. [3][4][16][19]*

| Finding | Interpretation | Next action |
| --- | --- | --- |
| Typical bilateral tender pretibial nodules | Compatible with erythema nodosum pattern. [1][18] | Proceed with targeted history, examination, and etiologic testing. [19][20] |
| Ulceration, sensory loss, cytopenias, or hepatosplenomegaly | Not a routine uncomplicated erythema nodosum presentation; consider infectious and systemic alternatives, including leprosy-associated reaction states. [16] | Obtain tissue diagnosis and evaluate systemic involvement. [16] |
| Recurrent oral/genital aphthae, uveitis, retinal vasculitis, or acneiform lesions | Supports a Behçet disease branch; erythema nodosum occurs in Behçet syndrome. [4][20] | Arrange ophthalmologic evaluation for ocular symptoms and assess Behçet classification features. [4] |
| Persistent, atypical, unilateral, or diagnostically uncertain nodules | Alternative panniculitis, vasculitis, infection, or malignancy may be present. [19][21] | Biopsy deeply enough to include subcutaneous fat. [3][11][12] |

## Use history and geography to select the etiologic tests

Testing should pursue the most plausible trigger rather than indiscriminate serology.

A focused initial evaluation should include review of recent pharyngitis, respiratory illness, diarrhea, tuberculosis exposure, travel or residence in fungal-endemic regions, pregnancy, medication changes, and symptoms of bowel, ocular, or mucosal inflammatory disease. Major associated categories include poststreptococcal infection, tuberculosis, deep fungal infection, sarcoidosis, inflammatory bowel disease, Yersinia enterocolitis, pregnancy, drugs, and idiopathic disease. [18][20]

Obtain a chest radiograph as part of the etiologic evaluation, particularly when cough, dyspnea, constitutional symptoms, tuberculosis risk, or sarcoidosis features are present. Chest imaging may identify early pulmonary findings of tuberculosis, sarcoidosis, or deep fungal infection. [19] Add tuberculosis testing when epidemiology or chest findings raise concern; a purified protein derivative test is specifically described as an assessment option. [19]

For recent or current pharyngitis, obtain throat culture and assess for evidence of recent streptococcal infection with anti-DNase B testing. The cutaneous eruption may follow pharyngitis by approximately 3 weeks, so a resolved sore throat does not exclude this branch. [19][20] For diarrheal disease, prioritize stool-directed evaluation for enteric infection, including Yersinia, while persistent diarrhea, abdominal pain, weight loss, or hematochezia should shift the workup toward inflammatory bowel disease. [18][20]
- Order CBC and inflammatory markers when fever, extensive disease, or systemic symptoms are present; leukocytosis and elevated erythrocyte sedimentation rate can accompany erythema nodosum but are not etiologically specific. [19]
- Review all recently started drugs, including sulfonamides, hormonal contraception, and other agents temporally associated with onset; pregnancy is also an established association. [20]
- Ask specifically about Southwest U.S. exposure for coccidioidomycosis and compatible pulmonary symptoms; deep fungal infection is a recognized etiologic branch. [18][20]
- In children, prioritize a history of group A streptococcal pharyngitis because it is described as the most common associated cause in U.S. children. [19][20]

*Etiologic branches and targeted next tests for erythema nodosum. [18][19][20]*

| Clinical branch | Clues that raise probability | Targeted evaluation |
| --- | --- | --- |
| Poststreptococcal disease | Pharyngitis within roughly 3 weeks before nodules. [20] | Throat culture and anti-DNase B testing. [19] |
| Pulmonary granulomatous or fungal disease | Cough, dyspnea, systemic symptoms, tuberculosis exposure, or residence/travel in endemic areas. [18][20] | Chest radiograph; add tuberculosis testing when indicated. [19] |
| Inflammatory bowel disease or infectious enterocolitis | Diarrhea, abdominal pain, hematochezia, weight loss, or established Crohn disease/ulcerative colitis. [17][18][20] | Evaluate intestinal activity; use stool-directed testing when enteric infection is suspected. [18][20] |
| Sarcoidosis | Erythema nodosum with pulmonary symptoms or chest imaging abnormalities. [18][19] | Chest radiograph to identify thoracic disease. [19] |
| Medication, pregnancy, or systemic inflammatory disease | New sulfonamide or oral contraceptive exposure, pregnancy, aphthae, ocular inflammation, or inflammatory arthritis. [4][20] | Stop or replace a plausible offending drug when clinically appropriate; evaluate for Behçet syndrome when mucocutaneous and ocular findings are present. [4][20] |

## Recognize inflammatory bowel disease, sarcoidosis, and Behçet disease branches

Extracutaneous findings determine whether skin-directed measures are insufficient.

In established inflammatory bowel disease, erythema nodosum is a recognized dermatologic extraintestinal manifestation and appears to mirror underlying bowel activity. [5][17] New gastrointestinal symptoms in a patient with erythema nodosum should therefore prompt bowel-directed assessment rather than repeated empiric treatment of skin nodules alone. In one IBD disease-activity framework, active disease thresholds were C-reactive protein greater than 5 mg/L, erythrocyte sedimentation rate greater than 30 mm/hour, and fecal calprotectin greater than 250 micrograms/g. [8]

For active Crohn disease with erythema nodosum, coordinate treatment with the IBD team and avoid allowing symptom relief from corticosteroids to substitute for control of intestinal inflammation. ACG guidance emphasizes sparing use of corticosteroids in Crohn disease, gradual discontinuation once begun, and addition of steroid-sparing therapy when needed; corticosteroids are relatively contraindicated in perforating complications such as abscess or fistula. [17]

Erythema nodosum is the most common nonspecific cutaneous lesion of sarcoidosis and may occur in up to 25% of sarcoidosis cases. [18] A chest radiograph is the first practical discriminator in patients with respiratory symptoms, hilar or pulmonary suspicion, or no alternate trigger. [19] Erythema nodosum associated with acute sarcoidosis has been linked to a high spontaneous remission rate, but pulmonary and other organ assessment should be guided by the chest findings and symptoms. [18]

Behçet disease should be considered when erythema nodosum-like lesions occur with recurrent oral aphthosis, genital aphthosis, eye disease, acneiform lesions, or pathergy. Under the 2014 International Criteria for Behçet's Disease, oral, genital, and ocular lesions each contribute diagnostic points, while skin lesions and pathergy contribute additional points. Ocular inflammation can include anterior uveitis, posterior uveitis, panuveitis, and retinal vasculitis with risk of irreversible vision loss; urgent ophthalmologic assessment is required for visual symptoms or red eye. [4]
- For known IBD, assess symptoms plus objective markers; CRP above 5 mg/L, ESR above 30 mm/hour, or fecal calprotectin above 250 micrograms/g support active inflammation in the reported framework. [8]
- For suspected Behçet disease, ask about oral and genital ulcers even if absent on the visit date; patient-reported recurrent aphthosis is included in the described criteria. [4]
- For eye pain, photophobia, blurred vision, or red eye with suspected Behçet disease, obtain prompt slit-lamp and retinal evaluation rather than attributing symptoms to a benign cutaneous flare. [4]

## Treat pain while directing definitive therapy at the cause

The immediate management plan should not obscure the etiologic diagnosis.

Management begins with identifying and removing or treating the precipitating condition: evaluate and manage confirmed streptococcal, enteric, mycobacterial, or fungal infection; discontinue a plausible medication trigger when feasible; and treat the associated inflammatory disorder when present. Erythema nodosum is a hypersensitivity reaction pattern associated with infections, inflammatory bowel disease, medications, pregnancy, sarcoidosis, and systemic inflammatory disease. [18][20]

For patients with Crohn disease, skin improvement should be interpreted alongside intestinal activity and complications. Corticosteroids should be used sparingly, tapered gradually once started, and not relied upon as durable maintenance therapy; concern for abscess or fistula is a major reason to avoid or defer corticosteroids until perforating complications are addressed. [17]

Reassess the diagnosis and repeat directed systemic evaluation when nodules recur without an identified trigger, fail to follow the expected inflammatory course, or develop atypical features. The etiologic spectrum includes infections, drugs, autoimmune and inflammatory disease, lymphoreticular malignancy, and other systemic disorders; recurrence should reopen the differential rather than automatically be labeled idiopathic. [19][20][21]
- Document medication timing carefully before concluding that a drug is causal; sulfonamides and oral contraceptives are recognized associations. [20]
- If inflammatory bowel disease is active, prioritize control of bowel inflammation and use objective markers to follow activity. [5][8][17]
- If sarcoidosis, tuberculosis, or deep fungal infection is suspected, use chest imaging findings to determine the next disease-specific pathway. [19]
- If a lesion ulcerates or systemic features such as neuropathy, pancytopenia, or hepatosplenomegaly emerge, obtain biopsy and broaden infectious and hematologic evaluation. [16]

*Follow-up triggers that change the erythema nodosum plan. [4][8][16][17][19]*

| Follow-up finding | Clinical implication | Action |
| --- | --- | --- |
| Rising bowel symptoms or CRP >5 mg/L, ESR >30 mm/hour, or fecal calprotectin >250 micrograms/g in a patient with IBD | Supports active intestinal inflammation in the reported activity framework. [8] | Escalate bowel-directed assessment and treatment with the IBD team. [5][17] |
| Visual symptoms or red eye with oral/genital aphthae | Potential uveitis, panuveitis, or retinal vasculitis in Behçet disease. [4] | Obtain urgent ophthalmologic examination. [4] |
| New ulceration, neuropathy, cytopenias, or hepatosplenomegaly | Suggests an alternative systemic or infectious nodular disorder. [16] | Perform deep skin biopsy and systemic evaluation. [16] |
| Persistent or recurrent nodules without a trigger | Requires renewed search for infection, drug exposure, inflammatory disease, and malignancy-associated processes. [19][21] | Revisit history, medication list, systemic review, imaging, and tissue diagnosis as indicated. [19] |

## References
1. Sweet's Syndrome and Erythema Nodosum - JAMA Network — jamanetwork.com — https://jamanetwork.com/journals/jamadermatology/fullarticle/477679
2. Clinical Characteristics of Erythema Nodosum and Associations ... — jamanetwork.com — https://jamanetwork.com/journals/jamadermatology/fullarticle/2813278
3. Rash on the arms and legs - The BMJ — www.bmj.com — https://www.bmj.com/content/351/bmj.h4131
4. Neurological involvement by Behçet’s syndrome: clinical features, diagnosis, treatment and outcome | Practical Neurology — pn.bmj.com — https://pn.bmj.com/content/23/5/386
5. Erythema Nodosum and Pyoderma Gangrenosum in Inflammatory Bowel Disease | NEJM Clinician — clinician.nejm.org — https://clinician.nejm.org/erythema-nodosum-pyoderma-gangrenosum-inflammatory-bowel-disease-JD200811140000001
6. Erythema nodosum caused by ascariasis and Chlamydophila ... — academic.oup.com — https://academic.oup.com/femspd/article/57/3/236/558922
7. Erythema nodosum caused by goserelin acetate sustained‐release ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/1756-185X.14692
8. Erythema nodosum as a marker for objective disease activity in ... — academic.oup.com — https://academic.oup.com/crohnscolitis360/article/8/1/otag013/8493206
9. Histopathologic spectrum of erythema nodosum - Thurber - 2006 — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1111/j.0303-6987.2006.00402.x
10. ECCO Guidelines on Extraintestinal Manifestations in Inflammatory ... — academic.oup.com — https://academic.oup.com/ecco-jcc/article/18/1/1/7205776
11. Leptospirosis presented with erythema nodosum on four limbs — academic.oup.com — https://academic.oup.com/omcr/article/2020/1/omz130/5716223
12. Early Primary Biliary Cirrhosis: A New Association with Erythema ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/10.1155/2010/121620
13. Erythema nodosum in an adolescent patient with cryopyrin ... — onlinelibrary.wiley.com — https://onlinelibrary.wiley.com/doi/full/10.1002/ccr3.1578
14. Apremilast for Recalcitrant Erythema Nodosum: A Case Series — journals.lww.com — https://journals.lww.com/00004342-202607000-00047
15. 22nd PANLAR Congress: Miami, FL, August 12-15 2020 : JCR - Ovid — journals.lww.com — https://journals.lww.com/jclinrheum/fulltext/2020/04001/22nd_panlar_congress__miami,_fl,_august_12_15_2020.1.aspx
16. Abstracts : Journal of Clinical Infectious Disease Society - Ovid — journals.lww.com — https://journals.lww.com/cids/fulltext/2025/07000/abstracts.10.aspx
17. ACG Clinical Guideline: Management of Crohn's Disease in Adults — journals.lww.com — https://journals.lww.com/ajg/fulltext/10.14309/ajg.0000000000003465~acg-clinical-guideline-management-of-crohns-disease-in
18. Erythema Nodosum - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/erythema-nodosum
19. Erythema Nodosum Leprosum - an overview — www.sciencedirect.com — https://www.sciencedirect.com/topics/medicine-and-dentistry/erythema-nodosum-leprosum
20. Erythema Nodosum - an overview | ScienceDirect Topics — www.sciencedirect.com — https://www.sciencedirect.com/topics/pharmacology-toxicology-and-pharmaceutical-science/erythema-nodosum
21. Recurrent Panniculitis in a Man With Asthma Receiving Treatment With Leukotriene-Modifying Agents - ScienceDirect — www.sciencedirect.com — https://www.sciencedirect.com/science/article/abs/pii/S002561961164593X
22. Index of Suspicion | Pediatrics In Review - AAP Publications — publications.aap.org — https://publications.aap.org/pediatricsinreview/article/24/8/276/75711/Index-of-Suspicion
23. Visual Diagnosis: A Child Who Has a Worsening Rash — publications.aap.org — https://publications.aap.org/pediatricsinreview/article/28/1/e1/34604/Visual-DiagnosisA-Child-Who-Has-a-Worsening-Rash
24. Dermatologic Manifestations of Systemic Diseases in Childhood — publications.aap.org — https://publications.aap.org/pediatricsinreview/article/42/12/655/183480/Dermatologic-Manifestations-of-Systemic-Diseases

## Editorial note

Prepared from cited clinical literature using Astra's research workflow. Verify recommendations against current guidance and patient-specific factors.